Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,363 | 182 | 99.1% |
| Gift | $38.80 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb, a division of Bausch Health US, LLC | $755.88 | 27 | $0 (2021) |
| Valeant Pharmaceuticals North America LLC | $711.28 | 15 | $0 (2017) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $533.49 | 30 | $0 (2024) |
| Oyster Point Pharma, Inc. | $281.74 | 11 | $0 (2024) |
| CooperVision Inc. | $234.03 | 10 | $0 (2022) |
| ABBVIE INC. | $229.82 | 12 | $0 (2024) |
| Alcon Vision LLC | $220.14 | 11 | $0 (2024) |
| Shire North American Group Inc | $204.20 | 10 | $0 (2018) |
| Sight Sciences, Inc. | $190.52 | 9 | $0 (2022) |
| Dompe US, Inc. | $179.69 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $431.30 | 18 | SUN PHARMACEUTICAL INDUSTRIES INC. ($97.64) |
| 2023 | $395.46 | 20 | Oyster Point Pharma, Inc. ($104.41) |
| 2022 | $606.23 | 30 | ABBVIE INC. ($130.30) |
| 2021 | $481.24 | 25 | SUN PHARMACEUTICAL INDUSTRIES INC. ($139.36) |
| 2020 | $455.57 | 24 | Sun Pharmaceutical Industries Inc. ($90.83) |
| 2019 | $442.98 | 18 | Johnson & Johnson Vision Care, Inc. ($126.31) |
| 2018 | $623.77 | 21 | Bausch & Lomb, a division of Bausch Health US, LLC ($467.37) |
| 2017 | $964.87 | 28 | Valeant Pharmaceuticals North America LLC ($711.28) |
All Payment Transactions
184 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Ophthalmology | ||||||
| 12/02/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $34.91 | General |
| Category: Dry eyes | ||||||
| 11/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Ophthalmology | ||||||
| 10/22/2024 | Alcon Vision LLC | TOTAL30 (Device) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Ophthalmology | ||||||
| 09/30/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: EYE CARE | ||||||
| 09/26/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: Ophthalmology | ||||||
| 09/16/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: Ophthalmology | ||||||
| 08/05/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Dry eyes | ||||||
| 07/24/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: EYE CARE | ||||||
| 07/22/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Ophthalmology | ||||||
| 06/11/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $31.98 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 04/29/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $31.07 | General |
| Category: SOLUTION/ DROPS | ||||||
| 04/29/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Ophthalmology | ||||||
| 04/08/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Ophthalmology | ||||||
| 03/18/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Ophthalmology | ||||||
| 02/09/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Dry eyes | ||||||
| 02/03/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Ophthalmology | ||||||
| 01/23/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/11/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $33.97 | General |
| Category: DRY EYE | ||||||
| 11/29/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: DRY EYE | ||||||
| 11/29/2023 | Alcon Vision LLC | Precision 1 (Device) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Ophthalmology | ||||||
| 11/29/2023 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Ophthalmology | ||||||
| 11/27/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Ophthalmology | ||||||
| 09/25/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Ophthalmology | ||||||
| 08/29/2023 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 354 | 480 | $56,195 | $28,239 |
| 2022 | 6 | 337 | 444 | $52,915 | $26,496 |
| 2021 | 6 | 339 | 464 | $56,085 | $29,945 |
| 2020 | 7 | 305 | 393 | $48,528 | $24,990 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 117 | 117 | $16,380 | $10,288 | 62.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 131 | $11,135 | $7,368 | 66.2% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 22 | 67 | $14,070 | $5,416 | 38.5% |
| 92133 | Imaging of optic nerve | Office | 2023 | 45 | 67 | $5,360 | $1,746 | 32.6% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 30 | 30 | $3,450 | $1,435 | 41.6% |
| 92134 | Imaging of retina | Office | 2023 | 38 | 44 | $3,520 | $1,286 | 36.5% |
| 92250 | Photography of the retina | Office | 2023 | 24 | 24 | $2,280 | $700.65 | 30.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 131 | 135 | $18,900 | $11,317 | 59.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 72 | 112 | $9,520 | $6,252 | 65.7% |
| 68761 | Closure of tear duct opening using plug | Office | 2022 | 19 | 60 | $12,600 | $4,539 | 36.0% |
| 92133 | Imaging of optic nerve | Office | 2022 | 50 | 65 | $5,200 | $1,749 | 33.6% |
| 92134 | Imaging of retina | Office | 2022 | 54 | 61 | $4,880 | $1,705 | 34.9% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 11 | 11 | $1,815 | $933.39 | 51.4% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 135 | 136 | $19,040 | $12,056 | 63.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 78 | 120 | $10,200 | $6,677 | 65.5% |
| 68761 | Closure of tear duct opening using plug | Office | 2021 | 21 | 70 | $14,700 | $6,168 | 42.0% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 53 | 78 | $6,240 | $2,057 | 33.0% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 13 | 13 | $2,145 | $1,610 | 75.1% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 39 | 47 | $3,760 | $1,378 | 36.7% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 111 | 112 | $15,640 | $10,821 | 69.2% |
| 68761 | Closure of tear duct opening using plug | Office | 2020 | 20 | 66 | $13,860 | $5,506 | 39.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 65 | 87 | $7,318 | $4,311 | 58.9% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2020 | 49 | 63 | $5,040 | $1,708 | 33.9% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 35 | 40 | $3,200 | $1,237 | 38.6% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 12 | 12 | $1,975 | $1,006 | 50.9% |
About Dr. Lam Dao, OD
Dr. Lam Dao, OD is a Optometrist healthcare provider based in Warwick, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609936137.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lam Dao, OD has received a total of $4,401 in payments from pharmaceutical and medical device companies, with $431.30 received in 2024. These payments were reported across 184 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($4,363).
As a Medicare-enrolled provider, Dao has provided services to 1,335 Medicare beneficiaries, totaling 1,781 services with total Medicare billing of $109,671. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Warwick, RI
- Active Since 12/12/2006
- Last Updated 12/06/2025
- Taxonomy Code 152W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609936137
Products in Payments
- ULTRA (Device) $1,031
- Cequa (Drug) $387.26
- XIIDRA (Drug) $334.06
- TYRVAYA (Drug) $281.74
- Multiple Brands Contact Lens (Device) $204.56
- OXERVATE (Drug) $179.69
- TearCare (Device) $170.21
- VUITY (Drug) $162.29
- Acuvue (Device) $143.64
- INFUSE (Device) $130.01
- BIOTRUE (Device) $124.59
- BTOD (Device) $120.68
- LUMIGAN (Drug) $118.10
- VYZULTA (Drug) $98.74
- DAILIES (Device) $93.94
- Precision 1 (Device) $77.25
- CEQUA (Drug) $58.12
- XDEMVY (Drug) $54.89
- MIEBO (Drug) $53.83
- INVELTYS (Drug) $53.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Warwick
Dr. Stephen Montaquila, O.d, O.D
Optometrist — Payments: $159,060
Dr. Maria Sampalis, O.d, O.D
Optometrist — Payments: $121,185
Dr. Georgia Patsiopoulos, O.d, O.D
Optometrist — Payments: $9,407
Alyssa Campagnone, Od, OD
Optometrist — Payments: $4,719
Dr. Stewart Rosenfeld, O.d, O.D
Optometrist — Payments: $3,551
Dr. Earle Scharff, Od, OD
Optometrist — Payments: $3,140